28 Jul 2010 10:36
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||||||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | |||||||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||
|
An acquisition or disposal of voting rights | x | |||||||||
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||||||||
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||||||||
|
An event changing the breakdown of voting rights |
| |||||||||
|
Other (please specify): |
|
| ||||||||
| 3. Full name of person(s) subject to the notification obligation:
| Gartmore Investment Limited | |||||||||
| 4. Full name of shareholder(s) (if different from 3.):
| Registered Owner: BNY GIL CLT Account Nominees Ltd
Beneficial Owner: Gartmore Fledgling Trust PLC | |||||||||
| 5. Date of the transaction and date on which the threshold is crossed or reached:
| 23 July 2010 | |||||||||
| 6. Date on which issuer notified:
| 27 July 2010 | |||||||||
| 7. Threshold(s) that is/are crossed or reached:
| 5% | |||||||||
| 8. Notified details: | ||||||||||
| A: Voting rights attached to shares
| ||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | ||||||
| Direct | Direct | Indirect | Direct | Indirect | ||||||
| Ordinary GB0034251727 | - | - | 10,610,000 |
| 10,610,000 |
| 5.075% | |||
|
| ||||||||||
| B: Qualifying Financial Instruments | |||||||||
| Resulting situation after the triggering transaction
| |||||||||
| Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted.
| % of voting rights | |||||
| N/A |
|
|
|
| |||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | |||||||||
| Resulting situation after the triggering transaction
| |||||||||
| Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights
| ||||
| N/A |
|
|
|
| Nominal | Delta
| |||
|
|
| ||||||||
| Total (A+B+C)
| |||||||||
| Number of voting rights | Percentage of voting rights | ||||||||
| 10,610,000 | 5.075% | ||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | |||||||||
|
| |||||||||
| Proxy Voting:
| |||||||||
| 10. Name of the proxy holder:
|
| ||||||||
| 11. Number of voting rights proxy holder will cease to hold:
|
| ||||||||
| 12. Date on which proxy holder will cease to hold voting rights:
|
| ||||||||
| 13. Additional information:
| Email contact: RDU@gartmore.com | ||||||||
| 14. Contact name:
| RDU | ||||||||
| 15. Contact telephone number:
| 0207 782 2324 | ||||||||